SIM
ALBO

Spark Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

Spark Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-363
Closed -$45K – 603
2013
Q2 		$45K Buy
+363
New +$37.8K 0.01% 425

Other funds holding ALBO

AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Spark Investment Management's ALBO Position: Q3 2013 in Review

Spark Investment Management sold out of Albireo Pharma Inc (ALBO) in Q3 2013, closing a stake of 363 shares — an estimated $45K sold.

Spark Investment Management first reported a position in ALBO in Q2 2013 and held it in 1 quarter. The position peaked at $45K in Q2 2013. 41 funds tracked by Wall St. Rank hold ALBO as of Q3 2013.

  • Spark Investment Management reported no remaining Albireo Pharma Inc position as of Q3 2013 after selling out during the quarter.
  • Spark Investment Management sold 363 Albireo Pharma Inc shares in Q3 2013, an estimated $45K.
  • Spark Investment Management first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 1 quarter.
  • Spark Investment Management's Albireo Pharma Inc position peaked at $45K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2013.

Based on Spark Investment Management's 13F filing for Q3 2013, filed 13 Nov 2013.